Annual report
150A.TEDINET S100W21B
Period2024-04-01 → 2025-03-31
Filed2025-06-23
StandardJapan GAAP
ConsolidatedYes
Data checks17 of 17 passed
Amended by S100YDX1 (2026-06-18).
Key figures · 98
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Operating income | ¥176m | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥185m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥180m | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥144m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥144m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥3.0bn | at 2025-03-31 | Cons. | Assets |
| Total liabilities | ¥944m | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.0bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.8bn | at 2024-03-31 | Cons. | Net assets |
| Cash and deposits | ¥811m | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥811m | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥138m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥691m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥168m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥25.67 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥25.22 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥362.46 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 68.3% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 7.1% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| Employees | 488 | at 2025-03-31 | Cons. | Number of employees |
| Revenue | ¥4.0bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥3.5bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥3.0bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.3bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.5bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥186m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥208m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥194m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥195m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥161m | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥83m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥143m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥189m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥195m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥153m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥145m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥188m | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥61m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥142m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.9bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥2.5bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥2.0bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.6bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥881m | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥889m | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥705m | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.0bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.8bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥663m | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥84m | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥774m | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.2bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥1.2bn | at 2024-03-31 | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥803m | at 2023-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥680m | at 2022-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥300m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥225m | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥145m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥117m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥195m | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥176m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥211m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥94m | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥486m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥27.33 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.29 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥41.25 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥15.33 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-7,203.3 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥26.85 | 2024-04-01 → 2025-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥31.27 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥364.07 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥334.63 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥-258.78 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥-352.71 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥-70,217.77 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 69.7% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.2% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.9% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.2% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 9.5% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 7.9% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.2% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 18.8% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.3% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 5,624,100 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,482,600 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,000 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,200 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 484 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 427 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 383 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 301 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 216 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 43
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2025-03-31 | 4 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2025-03-31 | ¥5m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2025-03-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥1m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2025-03-31 | ¥46m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2025-03-31 | ¥2m |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥2m |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥6m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥1m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥957m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥545m |
| Home Care Medicine Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥822,000 |
| Home Care Medicine Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥4m |
| Home Care Medicine Businessreportable segment | employees | at 2025-03-31 | 184 pure |
| Home Care Medicine Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.5bn |
| Home Care Medicine Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥1.5bn |
| Home Care Medicine Businessreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥390,000 |
| Home Care Medicine Businessreportable segment | segment assets | at 2025-03-31 | ¥295m |
| Home Care Medicine Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥165m |
| Regional Revitalization Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥803m |
| Regional Revitalization Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥139m |
| Regional Revitalization Businessreportable segment | employees | at 2025-03-31 | 273 pure |
| Regional Revitalization Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥2.5bn |
| Regional Revitalization Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥2.5bn |
| Regional Revitalization Businessreportable segment | segment assets | at 2025-03-31 | ¥1.7bn |
| Regional Revitalization Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥555m |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥804m |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥143m |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥4.0bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥4.0bn |
| —segment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥390,000 |
| —segment total | segment assets | at 2025-03-31 | ¥2.0bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥720m |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥804m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥143m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥4.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥4.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥1m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥721m |
| Home Care Medicine Businessreportable segment | employees | at 2025-03-31 | 184 pure |
| Regional Revitalization Businessreportable segment | employees | at 2025-03-31 | 273 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,281
| Item | Context | Value | Unit |
|---|---|---|---|
| Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial information | CurrentYearDuration | Text · Plus | |
| Consolidated balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of cash flows (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies for preparation of consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Number of consolidated subsidiaries and names of major consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Changes in scope of consolidation (text) | CurrentYearDuration | Text · Plus | |
| Number of unconsolidated subsidiaries and associates accounted for using equity method and names of major entities accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Disclosure about fiscal years etc of consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Disclosure of accounting policies (text) | CurrentYearDuration | Text · Plus | |
| Significant accounting estimates consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes new accounting standards not yet applied consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding amounts of notes and accounts receivable trade and contract assets (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding accumulated depreciation of property plant and equipment (text) | CurrentYearInstant | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amount of revenue from contracts with customers (text) | CurrentYearDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding loss on disposal of property plant and equipment (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding impairment loss (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding reclassification adjustments income taxes and tax effects relating to other comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYearDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Major components of assets and liabilities of consolidated subsidiary acquired by purchase of shares during reporting period (text) | CurrentYearDuration | Text · Plus | |
| Description of significant transactions not requiring use of cash or cash equivalents (text) | CurrentYearDuration | Text · Plus | |
| Notes leases consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes financial instruments consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes securities consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes retirement benefits consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes share options etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes tax effect accounting consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes business combinations consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes asset retirement obligations consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes real estate for lease etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes revenue recognition consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes segment information etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Description of reportable segments (text) | CurrentYearDuration | Text · Plus | |
| Disclosure of changes in reportable segments (text) | CurrentYearDuration | Text · Plus | |
| Explanation of measurements of sales profit loss asset liability and other items for each reportable segment (text) | CurrentYearDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYearDuration | Text · Plus | |
| Information for each product or service (text) | CurrentYearDuration | Text · Plus | |
| Revenues from external customers information for each region (text) | CurrentYearDuration | Text · Plus | |
| Property plant and equipment information for each region (text) | CurrentYearDuration | Text · Plus | |
| Information for each of main customers (text) | CurrentYearDuration | Text · Plus | |
| Description of factors which led to recognition of gain on bargain purchase (text) | CurrentYearDuration | Text · Plus | |
| Notes related parties consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes per share information consolidated financial statements (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 17 of 17 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |